trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['daisy', 't-dxd', 'tdxd', 'biomarker', 'marker ']
#esmo22: biomarker analysis on t-dxd mechanisms of resistance from #daisy trial: 1 spatial transcriptomic response to t-dxd different according to her2 expression;2 erbb2 hemizygous deletion associated with upfront tdxd resistance;3 slx4 mutations seem to induce dxd resistance. 
MD, Medical Oncologist????•Research Fellow at @JulesBordet Institute in Brussels???? Great interest in #BreastCancer and #ImmunoOncology